Addressing the Financial Barrier to Pediatric Dermatology Fellowship: A Call to Action for Systemic Change.
The study by Lee et al. highlights a critical and modifiable barrier to pediatric dermatology fellowship recruitment: financial disincentives. While approximately half of residents with an initial interest in any dermatology subspecialty experienced declining interest during training, the reasons differ significantly. Among the surveyed residents who lost interest in pursuing a pediatric dermatology fellowship, income concerns ranked as the most important deterrent. This contrasts sharply with micrographic surgery and dermatologic oncology (MSDO) fellowship, where financial concerns about future earnings were minimal (10 out of 11 concerns), and even with dermatopathology fellowship (6 out of 11). This discrepancy reveals an inequity specific to our specialty and warrants urgent systemic attention. Moreover, residents recognize the income disparity between pediatric dermatology and other subspecialties, and this disparity drives talented trainees away from our field. Identifying the barrier is only the first step. We must now advocate for systemic changes to address income inequality within dermatology subspecialties. We propose prioritizing two strategies: strengthening board certification value and improving reimbursement for pediatric care. First, we should work with the Accreditation Council for Graduate Medical Education (ACGME) and American Board of Dermatology (ABD) to align residency program faculty requirements in pediatric dermatology with those of other dermatology subspecialties. Unlike dermatopathology and micrographic dermatologic surgery/oncology, pediatric dermatology has historically not consistently required board-certified pediatric dermatologists as subspecialty faculty for residency training, a discrepancy that may inadvertently undervalue the expertise and rigor of our field. Although efforts to address this gap are already underway through proposed ACGME initiatives, the longstanding absence of equivalent training standards represents a broader structural failure to recognize pediatric dermatology as a subspecialty comparable to other dermatology board-certified subspecialties. If residents must be trained by board-certified dermatopathologists and MSDO faculty, the same standard should apply to pediatric dermatology. Additionally, general dermatologists may provide pediatric care without subspecialty certification, and being fellowship-trained, board-certified pediatric dermatologists currently confers no employment or remuneration advantage in many practice settings [2]. When additional fellowship training and subspecialty certification fail to confer meaningful differentiation, the incentive to pursue an extra year of training at a trainee salary in order to sit for subspecialty boards is substantially weakened. This interpretation aligns with Lee et al.'s findings, which identified the additional training time and trainee salary as the top two deterrents to fellowship pursuit among residents considering dermatopathology and MSDO. Second, pediatric dermatology must engage in targeted healthcare policy advocacy, particularly around reimbursement. Increasing pediatric dermatology representation on the Relative Value Scale Update Committee (RUC) would help ensure that the complexity and intensity of pediatric dermatologic care are appropriately reflected in valuation. Even more critically, advocacy for Medicaid reimbursement parity with Medicare is essential. Because pediatric dermatology practices disproportionately care for Medicaid-insured patients, persistently lower Medicaid reimbursement rates directly undermine practice viability and suppress long-term earning potential [3]. Lee and colleagues have provided pediatric dermatology with a roadmap by clearly identifying our field's unique barriers. Unlike challenges around mentorship or fellowship capacity, financial disincentives have concrete policy solutions. Addressing this inequity will require coordinated advocacy to strengthen certification standards, establish meaningful differentiation for board-certified pediatric dermatologists, increase pediatric representation in reimbursement policy, and achieve Medicaid payment parity. The evidence is clear. The path forward is defined. Now is the time for action. All the members of the Society for Pediatric Dermatology Workforce Committee have reviewed and approved the manuscript. Committee members include Kelly Cordoro, Marla Janke, Reesa Monir, Brea Prindaville, Adam Rubin, Kerrie Satcher, Jennifer Schoch, Nanette Silverberg. The authors declare no conflicts of interest. Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
Read more
